| Metric | შპს ნიუ ფარმა NEW PHARMA | შპს მედ ფარმასი გრუპი | შპს მედიმექსი |
|---|---|---|---|
| Growth | |||
| Revenue | ₾5.0m₾0 | ₾1.8m₾0 | ₾1.3m₾2.0m |
| Revenue growth | — | — | -35.1% |
| Profitability | |||
| EBITDA | -₾1.5m₾0 | ₾269k₾0 | ₾470k₾1.1m |
| EBITDA margin | -29.7% | 14.8% | 36.2%57.4% |
| Net profit | -₾1.5m₾0 | ₾229k₾0 | ₾8.8m-₾580k |
| Net margin | -29.7% | 12.5% | 675.1%-28.9% |
| Balance sheet | |||
| Total assets | ₾649k₾2.4m | ₾1.7m₾1.5m | ₾11.5m₾16.8m |
| Total equity | -₾1.1m₾357k | ₾1.3m₾1.1m | ₾11.2m₾208k |
| ROE | —0.0% | 17.8%0.0% | 78.2%-279.0% |